Metabolomics in Health and Disease Biology, Volume 104 covers this rapidly emerging field that aims for metabolic phenotyping and understanding the blueprint of metabolic pathways under various health and disease conditions by comprehensive analysis of metabolites. Chapters in this new release include Metabolomics approaches: Biomarkers to Disease mechanisms, Metabolomics in sleep disorders, Metabolomics in predicting the hallmark of Cancer Metabolism, Spectroscopic based rapid metabolic fingerprinting approaches for Cancer diagnosis, Lipidomics in assessing the health of osteoarthritis, Metabolomics Applications in Type 2 Diabetes mellitus, Metabolomics of Diabetic retinopathy, Metabolomics in Neurodegenerative disorders- Parkinson's disease, and Metabolomic of Neurodegenerative disorder: Alzheimer's Disease.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors to Volume 104 - p. iii 7. About the editor - p. iii 8. Preface - p. iii 9. Series editor’s preface - p. iii 10. Chapter One: Analytical platforms in metabolomics of health and disease - p. 2 11. Chapter Two: The chemometric models in metabolomics - p. 18 12. Chapter Three: Metabolomics in sleep disorders - p. 44 13. Chapter Four: Metabolomics in predicting the hallmark of cancer metabolism - p. 72 14. Chapter Five: Metabolomics/lipidomics of osteoarthritis and inflammation - p. 94 15. Chapter Six: Metabolomics applications in type 2 diabetes mellitus - p. 110 16. Chapter Seven: Metabolomics of diabetic retinopathy - p. 131 17. Chapter Eight: Metabolomics in neurodegenerative disorders—Parkinson’s disease - p. 162 18. Chapter Nine: Metabolomic of neurodegenerative disorder: Alzheimer’s disease - p. 185 19. Index - p. 213
Metabolomics in Health and Disease Biology, Volume 104 covers this rapidly emerging field that aims for metabolic phenotyping and understanding the blueprint of metabolic pathways under various health and disease conditions by comprehensive analysis of metabolites. Chapters in this new release include Metabolomics approaches: Biomarkers to Disease mechanisms, Metabolomics in sleep disorders, Metabolomics in predicting the hallmark of Cancer Metabolism, Spectroscopic based rapid metabolic fingerprinting approaches for Cancer diagnosis, Lipidomics in assessing the health of osteoarthritis, Metabolomics Applications in Type 2 Diabetes mellitus, Metabolomics of Diabetic retinopathy, Metabolomics in Neurodegenerative disorders- Parkinson's disease, and Metabolomic of Neurodegenerative disorder: Alzheimer's Disease.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors to Volume 104 - p. iii 7. About the editor - p. iii 8. Preface - p. iii 9. Series editor’s preface - p. iii 10. Chapter One: Analytical platforms in metabolomics of health and disease - p. 2 11. Chapter Two: The chemometric models in metabolomics - p. 18 12. Chapter Three: Metabolomics in sleep disorders - p. 44 13. Chapter Four: Metabolomics in predicting the hallmark of cancer metabolism - p. 72 14. Chapter Five: Metabolomics/lipidomics of osteoarthritis and inflammation - p. 94 15. Chapter Six: Metabolomics applications in type 2 diabetes mellitus - p. 110 16. Chapter Seven: Metabolomics of diabetic retinopathy - p. 131 17. Chapter Eight: Metabolomics in neurodegenerative disorders—Parkinson’s disease - p. 162 18. Chapter Nine: Metabolomic of neurodegenerative disorder: Alzheimer’s disease - p. 185 19. Index - p. 213
